(VIANEWS) - Emerson Electric Company (EMR), Johnson & Johnson (JNJ), Methanex Corporation (MEOH) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Emerson Electric Company (EMR)
12.1% sales growth and 25.77% return on equity
Emerson Electric Co., a technology and engineering company, provides solutions to industrial, commercial, and consumer markets worldwide.
Emerson Electric Company's sales growth this year is anticipated to be 9.7% and 6.5% for next year.
Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 17.06B for the twelve trailing months.
Volume
Today's last reported volume for Emerson Electric Company is 1979790 which is 12.77% below its average volume of 2269770.
Emerson Electric Company's sales growth is a negative 0% for the present quarter and 12.1% for the next. The company's growth estimates for the present quarter and the next is 22.5% and 8.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.77%.
Volatility
Emerson Electric Company's last day, last week, and last month's current volatility was 0.06%, 0.59%, and 0.74%, respectively.
Emerson Electric Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.70% (day), 1.13% (last week), and 1.60% (last month), respectively.
Emerson Electric Company's Stock Yearly Top and Bottom Value
Emerson Electric Company's stock is valued at $104.77 at 06:22 EST, below its 52-week high of $105.02 and way higher than its 52-week low of $63.16.
Emerson Electric Company's Moving Average
Emerson Electric Company's value is above its 50-day moving average of $99.75 and way higher than its 200-day moving average of $94.01.2. Johnson & Johnson (JNJ)
11.2% sales growth and 23.78% return on equity
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide.
Johnson & Johnson's sales growth this year is anticipated to be 14.4% and 3.7% for next year.
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 84.21B for the twelve trailing months.
Volume
Today's last reported volume for Johnson & Johnson is 6921120 which is 12.38% above its average volume of 6158630.
Johnson & Johnson's sales growth is a negative 0% for the present quarter and 11.2% for the next. The company's growth estimates for the ongoing quarter and the next is 7.3% and 20.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.78%.
Volatility
Johnson & Johnson's last day, last week, and last month's current volatility was 0.54%, 0.80%, and 0.58%, respectively.
Johnson & Johnson's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.97% (day), 1.01% (last week), and 0.99% (last month), respectively.
Johnson & Johnson's Stock Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $172.93 at 06:22 EST, under its 52-week high of $179.92 and way higher than its 52-week low of $133.65.
Johnson & Johnson's Moving Average
Johnson & Johnson's value is higher than its 50-day moving average of $172.55 and higher than its 200-day moving average of $166.31.Previous days news about Johnson & Johnson(JNJ)
- According to Bloomberg Quint on Wednesday, 25 August, "We look forward to discussing with public health officials a potential strategy for our Johnson & Johnson Covid-19 vaccine, boosting eight months or longer after the primary single-dose vaccination," Mammen said in a statement."
- According to Business Insider on Tuesday, 24 August, "Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that Encision has signed a Supply Agreement ("Agreement") with Auris Health, Inc. ("Auris"), part of the Johnson & Johnson Medical Devices Companies."
3. Methanex Corporation (MEOH)
11.1% sales growth and 9.15% return on equity
Methanex Corporation produces and supplies methanol in North America, the Asia Pacific, Europe, and South America.
Methanex Corporation's sales growth this year is anticipated to be 48.3% and a negative 12.7% for next year.
Year-on-year quarterly revenue growth grew by 108.5%, now sitting on 3.48B for the twelve trailing months.
Volume
Today's last reported volume for Methanex Corporation is 210801 which is 7.93% below its average volume of 228965.
Methanex Corporation's sales growth for the next quarter is 11.1%. The company's growth estimates for the ongoing quarter and the next is 207.8% and 446.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.15%.
Volatility
Methanex Corporation's last day, last week, and last month's current volatility was 5.86%, 3.77%, and 2.38%, respectively.
Methanex Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.62% (day), 3.99% (last week), and 3.76% (last month), respectively.
Methanex Corporation's Stock Yearly Top and Bottom Value
Methanex Corporation's stock is valued at $34.87 at 06:22 EST, way below its 52-week high of $49.27 and way above its 52-week low of $21.60.
Methanex Corporation's Moving Average
Methanex Corporation's value is above its 50-day moving average of $33.00 and under its 200-day moving average of $36.34.4. Cathay General Bancorp (CATY)
9% sales growth and 11.61% return on equity
Cathay General Bancorp operates as the holding company for Cathay Bank that offers various commercial banking products and services to individuals, professionals, and small to medium-sized businesses in the United States.
Cathay General Bancorp's sales growth this year is expected to be 7.8% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 35.6%, now sitting on 626.21M for the twelve trailing months.
Volume
Today's last reported volume for Cathay General Bancorp is 266151 which is 12.6% below its average volume of 304545.
Cathay General Bancorp's sales growth for the next quarter is 9%. The company's growth estimates for the present quarter and the next is 26.8% and 1.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.61%.
Volatility
Cathay General Bancorp's last day, last week, and last month's current volatility was 1.10%, 1.04%, and 1.27%, respectively.
Cathay General Bancorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.53% (day), 1.97% (last week), and 2.46% (last month), respectively.
Cathay General Bancorp's Stock Yearly Top and Bottom Value
Cathay General Bancorp's stock is valued at $39.69 at 06:22 EST, way under its 52-week high of $45.19 and way higher than its 52-week low of $20.59.